Financials

Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-9.65
Price to sales ratio
1 541.15

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
2965
PROK
ProKidney Corp. - Class A Ordinary Shares
1.55 USD-3.73%-20.10%-6.63%-25.48%468.19 M USD
2969
RZLT
Rezolute, Inc. - Common Stock
4.83 USD+1.90%-1.43%+11.03%-5.29%465.09 M USD
2978
OVID
Ovid Therapeutics Inc. - Common Stock
2.46 USD+1.23%-8.21%+9.33%+583.33%459.13 M USD
2989
PRTA
Prothena Corporation plc - Ordinary Shares
8.64 USD-2.15%-10.56%+5.88%+37.80%452.33 M USD

Frequently asked questions about Silence Therapeutics Plc - American Depository Share

What is the Silence Therapeutics Plc - American Depository Share stock price today?

The current price of Silence Therapeutics Plc - American Depository Share (SLN) is 9.75. Over the past 24 hours, the stock has changed by +4.95%. Follow the SLN chart for real-time price dynamics.

What is the stock ticker of Silence Therapeutics Plc - American Depository Share?

Silence Therapeutics Plc - American Depository Share trades under the ticker SLN. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Silence Therapeutics Plc - American Depository Share stock going up?

SLN has changed by -2.99% over the last week, +44.44% over the last month, and +50.70% over the last year. Review the chart to see whether the current move is part of a broader trend.

What was Silence Therapeutics Plc - American Depository Share net income for the last quarter?

Silence Therapeutics Plc - American Depository Share reported net income of -14.96 M for the last quarter. The previous quarter showed -11.77 M, which means net income changed by -27.08%.

How many employees does Silence Therapeutics Plc - American Depository Share have?

As of the latest available data, Silence Therapeutics Plc - American Depository Share has 88 employees. Workforce size can provide additional context about the company's scale and operations.

What is Silence Therapeutics Plc - American Depository Share EBITDA?

Silence Therapeutics Plc - American Depository Share EBITDA is -6.51 M, and its EBITDA margin is -1 542.42%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.

How can I buy Silence Therapeutics Plc - American Depository Share stock?

You can buy Silence Therapeutics Plc - American Depository Share (SLN) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Silence Therapeutics Plc - American Depository Share stock?

Investing in Silence Therapeutics Plc - American Depository Share requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the SLN chart and related analysis on metatrader.com as part of your research.

Silence Therapeutics Plc - American Depository Share

Silence Therapeutics is a London-based pharmaceutical company formed in 1994. The company has pioneered the development of short-interfering ribonucleic acid therapeutics for the treatment of rare diseases. Silence Therapeutics has offices in London, New Jersey, and Berlin, with its corporate headquarters located in Hammersmith, London.

News